Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Correct sequencing ensures alignment with diagnosis hierarchy requirements and payer billing rules
Walding is speaking as NativePath's co-founder and spokesperson, not as an independent researcher
Market Overview The India GLP-1 Receptor Agonist Market is valued at USD 82.2 million in 2024 with an approximated compound annual growth rate (CAGR) of 24.6% from 2024-2030, based on a comprehensive analysis approved by leading health organizations and market research firms
We specialise in chronic pain- and osteoarthritis management and have at our disposal nearly all of the above-mentioned treatment modalities
US$ 29.83
US$ 23.83
US$ 21.14
US$ 23.40
